HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Bergeron, A. Articles by Tazi, A. Search for Related Content PubMed PubMed Citation Articles by Bergeron, A. Articles by Tazi, A.

Characterisation of dendritic cell subsets in lung cancer micro-environments

¹ Université Paris 13, UPRES EA-3406, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Laboratoire d'hématologie biologique, Bobigny, ² Université Paris 7, UFR Denis Diderot, Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Saint-Louis, and ³ INSERM, U-552; Université Paris 7, UFR Denis Diderot, Paris, France.

CORRESPONDENCE: A. Tazi, Service de Pneumologie, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75475, Paris cedex 10, France. Fax: 33 142499395. E-mail: abdellatif.tazi{at}sls.ap-hop-paris.fr

Keywords: Chemokines, cytokines, immunohistochemistry, Langerhans cells, PCR

Received: October 1, 2005
Accepted July 14, 2006

The aim of the current study was to seek evidence for a correlation between mediators present in lung cancer micro-environments and subsets of dendritic cells (DCs) infiltrating these tumours.

Immunohistochemistry and recently available antibodies were used to define the phenotype of DCs present in surgical biopsies from 12 patients with lung carcinomas, and the local expression of chemokines potentially involved in the recruitment of these cells was evaluated, both at mRNA and protein levels. Real-time PCR was used to analyse the expression of mRNA coding for cytokines known to influence the maturation of DCs in vitro.

Different subsets of myeloid DCs were present in lung cancers, but no plasmocytoid DCs were identified. Both Langerhans cells and CD1a+/Langerin cells were interspersed among tumour cells, in numbers that were correlated to the amounts of CC chemokine ligand 20 produced in these tumours. In most specimens, DC-specific intercellular adhesion molecule-grabbing nonintegrin-postive DCs were also present at the periphery of the tumour beds. No DC-lysosomal associated membrane protein-positive DCs were identified and CD83+ DCs were rarely present in the tumour stroma. All tumours expressed interleukin (IL)-10, transforming growth factor-ß and vascular endothelial growth factor, whereas IL-12 was virtually absent.

Thus, various types of dendritic cells infiltrate lung carcinomas and display an immature phenotype, presumably because of the inhibitory cytokine micro-environment.

This article has been cited by other articles:

				M. Lommatzsch, K. Bratke, A. Bier, P. Julius, M. Kuepper, W. Luttmann, and J. C. Virchow Airway dendritic cell phenotypes in inflammatory diseases of the human lung Eur. Respir. J., November 1, 2007; 30(5): 878 - 886. [Abstract] [Full Text] [PDF]

				I. K. Demedts, K. R. Bracke, G. Van Pottelberge, D. Testelmans, G. M. Verleden, F. E. Vermassen, G. F. Joos, and G. G. Brusselle Accumulation of Dendritic Cells and Increased CCL20 Levels in the Airways of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 998 - 1005. [Abstract] [Full Text] [PDF]